Link Details

URL http://www.omrglobal.com/industry-reports/biomarkers-cancer-market/
Description Global biomarkers Cancer market is estimated to witness an exponential growth rate of 11.7% during 2017-2022. The growth of the market is backed by the increasing prevalence of cancer coupled with the rising awareness related to the usage of biomarkers Cancer at various stages of cancer. According to WHO, Cancer is the leading cause of morbidity as well as mortality at global level with around 14 million new cases registered in 2012. Over the next two decades, the number of new cases of cases if projected to rise by about 70%. Lack of physical activities, improper diet, frequent sun & UV exposure and increasing consumption of tobacco are some of the key factors that have attributed towards the increasing prevalence of cancer. Around 22% of cancer deaths are caused due to tobacco consumption and is regarded as the key risk factor for cancer. Along with it, few internal factors such as genetic mutation, hormonal imbalance and metabolic mutation also contributes towards the rise in cancer cases which in turn boosts the demand for biomarkers Cancer market. Moreover, increasing demand for clinical diagnosis in cancer’s early stages and growing geriatric population base further propels the usage rates of biomarkers Cancer . Increasing utilization of the biomarkers in surrogate endpoints & drug targets developments, rising interest among researchers & students regarding cancer diagnostic researchers and growing need for the biomarkers in cancer research are few critical success factors for the growth of the global biomarkers Cancer market. Technological advancements in the omics technology and rising demand for personalized medicine in therapies of cancer are projected to create growth opportunities for the global market which will attribute significantly towards the market value of the cancer biomarkers. However, poor reimbursement policies and high cost associated with cancer biomarkers are the key factors hampering the growth of the global market. Technical issues related to sample collection as well as storage further impede the growth of the global cancer biomarkers market.
Owner
Email
Add Time 2016-08-24 02:27:55
Category Science / Biology / Biotechnology